Skip to main navigation Skip to search Skip to main content

Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review

  • Christopher Mysko
  • , Stephanie Landi
  • , Huw Purssell
  • , A. Joy Allen
  • , Martin Prince
  • , Gary Lindsay
  • , Steven Rodrigues
  • , Jenny Irvine
  • , Oliver Street
  • , Deepankar Gahloth
  • , Sara MacLennan
  • , Karen Piper Hanley
  • , Neil Hanley
  • , Varinder Singh Athwal* (Corresponding Author)
  • *Corresponding author for this work
  • University of Manchester
  • Manchester University NHS Foundation Trust
  • Roche Diagnostics Ltd.
  • Vocal
  • University of Birmingham
  • University Hospitals Birmingham NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

6 Downloads (Pure)

Abstract

Background
Hepatocellular carcinoma (HCC) remains a deadly cancer in the UK despite advancements in curative therapies. Societal conditions and health inequalities influence the development of chronic liver disease and outcomes from complications including HCC. Scoping this emergent evidence-base is required to inform research and solutions for the NHS.

Methods
A PRISMA scoping review was performed up to September 2023. Articles exploring health inequalities in HCC involving the UK population were included.

Results
This review has characterised axes of health inequality and their impact across the HCC care continuum in the UK. Studies predominantly employed a cohort design or population-based analyses, with meta-analyses of surveillance utilisation including only a single UK study. These methodologies provided an appropriate lens to understand longitudinal trends and identify disadvantaged groups. However, important evidence gaps remain, including exploration of patient perspectives, intersectional analyses, and statistical measures of socioeconomic inequity in HCC.

Conclusions
HCC is a rapidly growing cause of cancer mortality and disproportionally affects underserved groups, presenting a major public health concern. Further research is required to innovate and evaluate surveillance and management pathways to reduce systemic inequities. Direction is needed at the national level to improve prevention, early diagnosis and access to curative treatment.
Original languageEnglish
Article number13
Number of pages10
JournalBJC reports
Volume3
Issue number1
Early online date3 Mar 2025
DOIs
Publication statusPublished - 3 Mar 2025

Data Availability Statement

No datasets were generated or analysed during the current study.

Funding

CM and VSA are funded by the NHS Cancer Programme (NCPC02013) and supported by Small Business Research Initiative (SBRI) Healthcare.

FundersFunder number
NHS Cancer ProgrammeNCPC02013
SBRI Healthcare

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review'. Together they form a unique fingerprint.

    Cite this